This company listing is no longer active
BYOT Stock Overview
Develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Byotrol plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.001 |
| 52 Week High | UK£0.026 |
| 52 Week Low | UK£0.0005 |
| Beta | -0.51 |
| 1 Month Change | -33.33% |
| 3 Month Change | -84.00% |
| 1 Year Change | -94.12% |
| 3 Year Change | -98.58% |
| 5 Year Change | -95.74% |
| Change since IPO | -99.66% |
Recent News & Updates
Recent updates
With EPS Growth And More, Byotrol (LON:BYOT) Is Interesting
Dec 08
If You Like EPS Growth Then Check Out Byotrol (LON:BYOT) Before It's Too Late
Apr 07Here's Why We Don't Think Byotrol's (LON:BYOT) Statutory Earnings Reflect Its Underlying Earnings Potential
Feb 18Is Byotrol plc's (LON:BYOT) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 28Here's Why We Think Byotrol (LON:BYOT) Is Well Worth Watching
Jan 07How Much is Byotrol's (LON:BYOT) CEO Getting Paid?
Dec 16Byotrol plc's (LON:BYOT) P/E Is On The Mark
Nov 25
Shareholder Returns
| BYOT | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -20.0% | -0.6% | 0.4% |
| 1Y | -94.1% | -23.2% | 3.9% |
Return vs Industry: BYOT underperformed the UK Chemicals industry which returned -37.5% over the past year.
Return vs Market: BYOT underperformed the UK Market which returned 1.4% over the past year.
Price Volatility
| BYOT volatility | |
|---|---|
| BYOT Average Weekly Movement | 66.3% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BYOT's share price has been volatile over the past 3 months.
Volatility Over Time: BYOT's weekly volatility has increased from 34% to 66% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 36 | David Traynor | byotrolplc.com |
Byotrol plc develops and commercialize antimicrobial technologies and products in the United Kingdom, North America, and internationally. The company operates through Professional and Consumer segments. Its product portfolio includes Actizone, a antimicrobial technology which improves cleaning performance and long-lasting protection against bacteria; and Byotrol, a long-lasting antimicrobial protection for various applications including bathroom cleaners to multi-surface wipes.
Byotrol plc Fundamentals Summary
| BYOT fundamental statistics | |
|---|---|
| Market cap | UK£453.89k |
| Earnings (TTM) | -UK£1.85m |
| Revenue (TTM) | UK£4.38m |
0.1x
P/S Ratio-0.2x
P/E RatioIs BYOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BYOT income statement (TTM) | |
|---|---|
| Revenue | UK£4.38m |
| Cost of Revenue | UK£2.52m |
| Gross Profit | UK£1.86m |
| Other Expenses | UK£3.72m |
| Earnings | -UK£1.85m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0041 |
| Gross Margin | 42.51% |
| Net Profit Margin | -42.33% |
| Debt/Equity Ratio | 19.7% |
How did BYOT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/30 15:09 |
| End of Day Share Price | 2024/04/30 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Byotrol plc is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Sanders | Arbuthnot Securities Limited |
| David Buxton | Cavendish |
| Andrew Murray Darley | Cavendish |